Ingemar Björk

10.6k total citations · 1 hit paper
170 papers, 9.0k citations indexed

About

Ingemar Björk is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Ingemar Björk has authored 170 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 59 papers in Hematology and 57 papers in Cancer Research. Recurrent topics in Ingemar Björk's work include Protease and Inhibitor Mechanisms (57 papers), Blood Coagulation and Thrombosis Mechanisms (47 papers) and Proteoglycans and glycosaminoglycans research (36 papers). Ingemar Björk is often cited by papers focused on Protease and Inhibitor Mechanisms (57 papers), Blood Coagulation and Thrombosis Mechanisms (47 papers) and Proteoglycans and glycosaminoglycans research (36 papers). Ingemar Björk collaborates with scholars based in Sweden, United States and Slovenia. Ingemar Björk's co-authors include Steven T. Olson, Birgitta Nordenman, Ulf Lindahl, Joseph D. Shore, Åke Danielsson, Wayne W. Fish, Kerstin Nordling, K Ylinenjärvi, Magnus Höök and John J. Hopwood and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Ingemar Björk

168 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombin

1976 373 citations Ingemar Björk et al. FEBS Letters profile →

Peers

Countries citing papers authored by Ingemar Björk

Since Specialization

Citations

This map shows the geographic impact of Ingemar Björk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingemar Björk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingemar Björk more than expected).

Fields of papers citing papers by Ingemar Björk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingemar Björk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingemar Björk. The network helps show where Ingemar Björk may publish in the future.

Co-authorship network of co-authors of Ingemar Björk

This figure shows the co-authorship network connecting the top 25 collaborators of Ingemar Björk. A scholar is included among the top collaborators of Ingemar Björk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingemar Björk. Ingemar Björk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antithrombin III Phenylalanines 122 and 121 Contribute to Its High Affinity for Heparin and Its Conformational Activation 2003 ·Journal of Biological Chemistry ·Mohamad Aman Jairajpuri, (unknown), Umesh R. Desai, Steven T. Olson, Ingemar Björk, Susan Bock	49
2	Contributions of individual residues in the N-terminal region of cystatin B (stefin B) to inhibition of cysteine proteinases 2003 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Ewa Pol, Ingemar Björk	12
3	The N‐terminal region of cystatin A (stefin A) binds to papain subsequent to the two hairpin loops of the inhibitor. Demonstration of two‐step binding by rapid‐kinetic studies of cystatin A labeled at the N‐terminus with a fluorescent reporter group 2000 ·Protein Science ·Sergio Estrada, (unknown), Ingemar Björk, (unknown)	6
4	Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration by release of loop anchoring through mutation of His110 2000 ·FEBS Letters ·(unknown), Joanne C. Krupa, John S. Mort, Magnus Abrahamson, Ingemar Björk	43
5	Acidic pH as a physiological regulator of human cathepsin L activity 1999 ·European Journal of Biochemistry ·Boris Turk, Iztok Dolenc, Brigita Lenar≷cic̆, Igor Križaj, Vito Türk, Joseph G. Bieth, Ingemar Björk	65
6	The epidermal growth factor precursor 1999 ·European Journal of Biochemistry ·Carmen Valcarce, Ingemar Björk, J Stenflo	11
7	Hydrophobic sequences can substitute for the wild‐type N‐terminal sequence of cystatin A (stefin A) in tight binding to cysteine proteinases 1999 ·European Journal of Biochemistry ·K Ylinenjärvi, Mikael Widersten, Ingemar Björk	6
8	Inactivation of papain by antithrombin due to autolytic digestion: a model of serpin inactivation of cysteine proteinases 1998 ·Biochemical Journal ·Ingemar Björk, Kerstin Nordling, (unknown), Ulf Hellman, Steven T. Olson	19
9	Effect of Individual Carbohydrate Chains of Recombinant Antithrombin on Heparin Affinity and on the Generation of Glycoforms Differing in Heparin Affinity 1997 ·Archives of Biochemistry and Biophysics ·Steven T. Olson, (unknown), (unknown), Ingemar Björk, Gerd Zettlmeißl	47
10	Apparent Formation of Sodium Dodecyl Sulfate-stable Complexes between Serpins and 3,4-Dichloroisocoumarin-inactivated Proteinases Is Due to Regeneration of Active Proteinase from the Inactivated Enzyme 1997 ·Journal of Biological Chemistry ·Steven T. Olson, Richard Swanson, Philip A. Patston, Ingemar Björk	7
11	Structural Comparison of the Precursor and the Mature Form of Napin, the 2S Storage Protein in Brassica napus 1996 ·European Journal of Biochemistry ·Eva Murén, Bo Ek, Ingemar Björk, Lars Rask	20
12	Identification of bovine stefin A, a novel protein inhibitor of cysteine proteinases 1995 ·FEBS Letters ·Boris Turk, Anka Ritonja, Ingemar Björk, Veronika Stoka, Iztok Dolenc, Vito Türk	35
13	[30] Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin 1993 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Steven T. Olson, Ingemar Björk, Joseph D. Shore	227
14	Immunologic evidence for insertion of the reactive-bond loop of antithrombin into the A .beta.-sheet of the inhibitor during trapping of target proteinases 1993 ·Biochemistry ·Ingemar Björk, Kerstin Nordling, Steven T. Olson	55
15	Different roles of the two disulfide bonds of the cysteine proteinase inhibitor, chicken cystatin, for the conformation of the active protein 1992 ·Biochemistry ·Ingemar Björk, K Ylinenjärvi	14
16	Biphasic transition curve on denaturation of chicken cystatin by guanidinium chloride Evidence for an independently unfolding structural region 1992 ·FEBS Letters ·Ingemar Björk, Ewa Pol	10
17	Isolation and Phagocytic Properties of Neutrophils and Other Phagocytes from Nonmastitic Bovine Milk 1991 ·Journal of Dairy Science ·(unknown), Kerstin Nordling, Ingemar Björk	19
18	Binding of heparin to human high molecular weight kininogen 1989 ·Biochemistry ·Ingemar Björk, Steven T. Olson, (unknown), Joseph D. Shore	49
19	Kinetics of binding of chicken cystatin to papain 1989 ·Biochemistry ·Ingemar Björk, (unknown), K Ylinenjärvi	53
20	Properties of the complex between α2-macroglobulin and brinase, a proteinase from with thrombolytic effect 1988 ·Thrombosis Research ·(unknown), (unknown), Karolina Törneke, (unknown), Ingemar Björk	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact